Clinical trial · Interventional
Local Cecal Cancer - Optimization of Surgical Treatment
Study of the Oncological Outcomes of Ileocecal Resection With D3 for Cecal Cancer
NCT06121089CI-TRIAL-00071418LoCCOSTerecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right hemicolectomy(RHC) for cecal cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cecal Neoplasms | — | UNRESOLVED | — |
| Colonic Neoplasms Malignant | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ileocecal resection with extended D3 lymphadenectomy. | Procedure | — | UNRESOLVED |
| Right hemicolectomy with D3 lymphadenectomy. | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Laparoscopy ileocecal resection with extended D3 lymphadenectomy.
- description
- Ileocecal resection with extended D3 lymphadenectomy.
- interventionNames
- Procedure: ileocecal resection with extended D3 lymphadenectomy.
- type
- EXPERIMENTAL
- label
- Laparoscopy right hemicolectomy with D3 lymphadenectomy.
- description
- Right hemicolectomy with D3 lymphadenectomy
- interventionNames
- Procedure: Right hemicolectomy with D3 lymphadenectomy.
Primary outcomes (3)
- measure
- Overall survival.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * At least 18 years of age. * ECOG status 0-2. * Histologically confirmed adenocarcinoma of the colon. * Clinical stage T1-3; N+; M0. * The physical status from ASA classification I, II, III or IV. * Written informed consent. Exclusion Criteria: * Synchronous or metachronous malignancy. * Locally-advanced tumor (T\>3). * Presence of distant metastases (M1). * Complicated tumor: obstruction, perforation. * Neoadjuvant chemotherapy. * Medical contraindications for surgical treatment. * Pregnancy or breast feeding. * Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.